Genky DrugStores Co., Ltd.
9267.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | ¥201 | ¥185 | ¥169 | ¥155 |
| % Growth | 8.6% | 9.3% | 9.3% | – |
| Cost of Goods Sold | ¥160 | ¥147 | ¥135 | ¥124 |
| Gross Profit | ¥41 | ¥38 | ¥35 | ¥31 |
| % Margin | 20.4% | 20.4% | 20.4% | 20% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥31 | ¥24 | ¥23 | ¥21 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥5 | ¥5 | ¥4 |
| Operating Expenses | ¥31 | ¥29 | ¥28 | ¥25 |
| Operating Income | ¥10 | ¥9 | ¥7 | ¥6 |
| % Margin | 4.8% | 4.9% | 4% | 3.7% |
| Other Income/Exp. Net | ¥0 | -¥0 | -¥0 | ¥0 |
| Pre-Tax Income | ¥10 | ¥9 | ¥7 | ¥6 |
| Tax Expense | ¥3 | ¥2 | ¥2 | ¥2 |
| Net Income | ¥7 | ¥6 | ¥5 | ¥4 |
| % Margin | 3.5% | 3.4% | 2.8% | 2.9% |
| EPS | 232.49 | 207.94 | 156.89 | 145.59 |
| % Growth | 11.8% | 32.5% | 7.8% | – |
| EPS Diluted | 232.02 | 207.91 | 156.79 | 145.44 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥6 | ¥6 | ¥5 | ¥5 |
| EBITDA | ¥16 | ¥14 | ¥12 | ¥11 |
| % Margin | 8.2% | 7.8% | 6.9% | 6.9% |